HIMCH
BMRN icon

Hartford Investment Management Co (HIMCO)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,721
Closed -$252K – 631
2016
Q3 		$252K Sell
2,721
-185
-6% -$17.4K 0.01% 554
2016
Q2 		$226K Buy
2,906
+70
+2% +$5.95K ﹤0.01% 570
2016
Q1 		$234K Sell
2,836
-139
-5% -$11.3K ﹤0.01% 560
2015
Q4 		$312K Sell
2,975
-401
-12% -$41.9K 0.01% 543
2015
Q3 		$356K Sell
3,376
-64
-2% -$8.55K 0.01% 536
2015
Q2 		$471K Sell
3,440
-489
-12% -$60.6K 0.01% 527
2015
Q1 		$490K Sell
3,929
-486
-11% -$51.5K 0.01% 519
2014
Q4 		$399K Sell
4,415
-1,100
-20% -$91.5K 0.01% 530
2014
Q3 		$398K Sell
5,515
-756
-12% -$49.7K 0.01% 582
2014
Q2 		$390K Sell
6,271
-960
-13% -$58K 0.01% 611
2014
Q1 		$493K Buy
7,231
+101
+1% +$7.44K 0.01% 590
2013
Q4 		$502K Sell
7,130
-2,370
-25% -$161K 0.01% 600
2013
Q3 		$686K Buy
9,500
+350
+4% +$23.3K 0.01% 542
2013
Q2 		$510K Buy
+9,150
New +$570K 0.01% 589

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s BMRN Position: Q4 2016 in Review

Hartford Investment Management Co (HIMCO) sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2016, closing a stake of 2,721 shares — an estimated $252K sold.

Hartford Investment Management Co (HIMCO) first reported a position in BMRN in Q2 2013 and held it in 14 quarters. The position peaked at $686K in Q3 2013. 415 funds tracked by Wall St. Rank hold BMRN as of Q4 2016.

  • Hartford Investment Management Co (HIMCO) reported no remaining BioMarin Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 2,721 BioMarin Pharmaceuticals shares in Q4 2016, an estimated $252K.
  • Hartford Investment Management Co (HIMCO) first reported a position in BioMarin Pharmaceuticals in Q2 2013 and held it in 14 quarters.
  • Hartford Investment Management Co (HIMCO)'s BioMarin Pharmaceuticals position peaked at $686K in Q3 2013.
  • 415 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2016.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q4 2016, filed 10 Feb 2017.